Two decades with omalizumab: what we still have to learn
Cristoforo Incorvaia,1 Marina Mauro,2 Elena Makri,1 Gualtiero Leo,3 Erminia Ridolo4 1Cardiac/Pulmonary Rehabilitation, ASST Pini/CTO, Milan, Italy; 2Allergy Department, Sant’Anna Hospital, Como, Italy; 3Pediatric Allergy and Respiratory Pathophysiology Unit, Department of Pediatrics, Vitto...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | Biologics : Targets & Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/two-decades-with-omalizumab-what-we-still-have-to-learn-peer-reviewed-article-BTT |